SCHEMBL16966166

SCHEMBL16966166

NC(=O)OC1C2C=CC(C2)C1Nc1nc(Nc2ccc3c(c2)CCC(N2CCOCC2)CC3)ncc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 15/20 0.63
INSR P06213 9/20 0.60
PTK2 Q05397 3/20 0.60
NUAK1 O60285 1/20 0.60
CHEK2 O96017 1/20 0.60
FES P07332 1/20 0.60
FER P16591 1/20 0.60
FLT4 P35916 1/20 0.60
FLT3 P36888 1/20 0.60
MAPK8 P45983 1/20 0.60
RPS6KA3 P51812 1/20 0.60
TNK2 Q07912 1/20 0.60
MAP4K2 Q12851 1/20 0.60
PTK6 Q13882 1/20 0.60
RPS6KA2 Q15349 1/20 0.60
RPS6KA1 Q15418 1/20 0.60
RPS6KA6 Q9UK32 1/20 0.60
MET P08581 1/20 0.50
KDR P35968 4/20 0.48
AURKB Q96GD4 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16965989 1.00 ALK (0.63) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966106 0.92 ALK (0.64) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966081 0.92 ALK (0.60) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966256 0.91 ALK (0.62) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966203 0.90 ALK (0.51) ALKINSRPTK2NUAK1CHEK2
SCHEMBL2060990 0.89 ALK (0.76) ALKINSRPTK2NUAK1CHEK2
SCHEMBL886699 0.89 ALK (0.76) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966156 0.88 ALK (0.53) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966086 0.88 ALK (0.82) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966253 0.85 ALK (0.83) ALKINSRPTK2NUAK1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2684874-B1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors CEPHALON INC (US) 2017-05-17 EP claimed
EP-2222647-B1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON INC (US) 2015-08-05 EP claimed